Larotrectinib Produces Remarkable Responses in NTRK Fusion-Positive CNS Tumors

Larotrectinib can produce rapid and durable responses in children with NTRK fusion-positive CNS tumors, updated data suggest.

Related Keywords

Denmark ,Copenhagen ,Køavn ,Karsten Nysom ,University Hospital Rigshospitalet ,International Symposium On Pediatric Neuro ,International Symposium ,Pediatric Neuro Oncology ,Loxo Oncology ,